New mRNA vaccine aims to prevent shingles in older adults
NCT ID NCT07205796
First seen Oct 31, 2025 · Last updated May 02, 2026 · Updated 26 times
Summary
This study tests a new mRNA vaccine called IN001 to prevent shingles (herpes zoster) in healthy adults aged 50 to 79. About 480 participants will receive two doses of either the new vaccine or an existing one. Researchers will check how well the vaccine triggers the immune system and monitor for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.